JPH1149701A - 抗癌剤 - Google Patents

抗癌剤

Info

Publication number
JPH1149701A
JPH1149701A JP9223063A JP22306397A JPH1149701A JP H1149701 A JPH1149701 A JP H1149701A JP 9223063 A JP9223063 A JP 9223063A JP 22306397 A JP22306397 A JP 22306397A JP H1149701 A JPH1149701 A JP H1149701A
Authority
JP
Japan
Prior art keywords
vegf
antibody
bfgf
vpf
monoclonal antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9223063A
Other languages
English (en)
Japanese (ja)
Other versions
JPH1149701A5 (enExample
Inventor
Yoshino Yoshitake
佳乃 吉竹
Katsuzo Nishikawa
克三 西川
Mitsuru Osawa
満 大澤
Makoto Asano
誠 浅野
Ayako Koda
綾子 幸田
Hideo Suzuki
日出夫 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toagosei Co Ltd
Mitsubishi Kagaku Iatron Inc
Original Assignee
Iatron Laboratories Inc
Toagosei Co Ltd
Mitsubishi Kagaku Iatron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iatron Laboratories Inc, Toagosei Co Ltd, Mitsubishi Kagaku Iatron Inc filed Critical Iatron Laboratories Inc
Priority to JP9223063A priority Critical patent/JPH1149701A/ja
Publication of JPH1149701A publication Critical patent/JPH1149701A/ja
Publication of JPH1149701A5 publication Critical patent/JPH1149701A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP9223063A 1997-08-04 1997-08-04 抗癌剤 Pending JPH1149701A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9223063A JPH1149701A (ja) 1997-08-04 1997-08-04 抗癌剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9223063A JPH1149701A (ja) 1997-08-04 1997-08-04 抗癌剤

Publications (2)

Publication Number Publication Date
JPH1149701A true JPH1149701A (ja) 1999-02-23
JPH1149701A5 JPH1149701A5 (enExample) 2005-04-21

Family

ID=16792256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9223063A Pending JPH1149701A (ja) 1997-08-04 1997-08-04 抗癌剤

Country Status (1)

Country Link
JP (1) JPH1149701A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003503313A (ja) * 1999-06-03 2003-01-28 ジェシー エル エス オウ 細胞増殖及び細胞死を変調する方法及び組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003503313A (ja) * 1999-06-03 2003-01-28 ジェシー エル エス オウ 細胞増殖及び細胞死を変調する方法及び組成物

Similar Documents

Publication Publication Date Title
Matsuzaki et al. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.
US5891996A (en) Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use
US6419928B1 (en) Monoclonal antibodies to transforming growth factor-beta and methods of use
JP3293823B2 (ja) 肝細胞成長因子（ｈｇｆ）レセプターの部分切除形態
EP0521842B1 (en) Tumor antigen specific antibody
US6024955A (en) Peptides and monoclonal antibodies
US6676940B2 (en) Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
JP2002532113A (ja) 切断ｖｅｇｆ−ｄの抗体及びその利用法
JP3455743B2 (ja) ヒトｐｄｇｆベータ・レセプタに対する阻害性免疫グロブリン・ポリペプチド
WO2023174029A1 (zh) 一种prlr抗原结合蛋白及其制备方法和应用
JPH1149701A (ja) 抗癌剤
JP2003529370A (ja) 血管浸透性に対する有害な作用を有さないｖｅ−カドヘリンに対する拮抗薬抗体
JPH07330795A (ja) ペプチドおよびモノクローナル抗体
JP3483556B2 (ja) 細胞接着阻害抗体およびこれを利用する細胞接着阻害剤
JPH06189787A (ja) モノクローナル抗体、ハイブリドーマおよびそれらの用途
EP2927243A1 (en) Anti-vasohibin 2 antibody
CN113321730B (zh) Cldn18.2抗体及其应用
JP3232415B2 (ja) モノクローナル抗体，その製造法および用途
JPH10114680A (ja) 制癌剤
AU675073B2 (en) Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
JP2871743B2 (ja) モノクローナル抗体及びその抗体を分泌するハイブリドーマ
JPH03502446A (ja) 動物およびヒトのレクチン類の少なくとも一部分の配列を再現するアミノ酸配列，それを得る方法，およびその診断および治療への用途
JPH0759588A (ja) 増殖因子レセプターに対するモノクローナル抗体の製造方法及び抗ｃ−ｅｒｂＢ−２モノクローナル抗体
JP3472664B2 (ja) 抗繊維芽細胞増殖因子５モノクローナル抗体
JPH11302193A (ja) 血管新生阻害剤

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040324

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20040326

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040324

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040614

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040614

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20051026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071002

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080219